HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 176 filers reported holding HERON THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $735,158 | +452.8% | 294,063 | +828.0% | 0.00% | – |
| Q3 2022 | $133,000 | -90.5% | 31,689 | -93.7% | 0.00% | -100.0% |
| Q2 2022 | $1,405,000 | -74.5% | 503,685 | -16.4% | 0.01% | -73.7% |
| Q4 2021 | $5,502,000 | +7.1% | 602,613 | +25.3% | 0.02% | -9.5% |
| Q3 2021 | $5,139,000 | -15.4% | 480,772 | +22.8% | 0.02% | -27.6% |
| Q2 2021 | $6,075,000 | +29.7% | 391,433 | +104.2% | 0.03% | -6.5% |
| Q1 2019 | $4,685,000 | +71.7% | 191,698 | +82.2% | 0.03% | +55.0% |
| Q4 2018 | $2,729,000 | -72.7% | 105,205 | -66.6% | 0.02% | -55.6% |
| Q3 2018 | $9,984,000 | -83.2% | 315,454 | -85.3% | 0.04% | -81.9% |
| Q1 2018 | $59,333,000 | +101.1% | 2,149,740 | +31.9% | 0.25% | +169.6% |
| Q4 2017 | $29,501,000 | +60.0% | 1,629,881 | +42.7% | 0.09% | +27.8% |
| Q3 2017 | $18,443,000 | +9.0% | 1,141,955 | -6.5% | 0.07% | +2.9% |
| Q2 2017 | $16,916,000 | -5.8% | 1,221,403 | +2.1% | 0.07% | -16.7% |
| Q1 2017 | $17,951,000 | – | 1,196,715 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |